Genetic Testing Markets - Global Market Analysis with Forecasts to 2027: Genetic Testing has Crossed the Chasm and is Now Growing in Every Area

26 Feb 2024
www.prnewswire.com
Acquisition
DUBLIN, Feb. 26, 2024 /PRNewswire/ -- The "Genetic Testing Markets. Global Market Analysis with Forecasts by Applications, Technologies, Products and Users with Executive and Consultant Guides 2023 to 2027" report has been added to
ResearchAndMarkets.com's offering.
Unlimited growth potential? Genetic Testing has crossed the chasm and is now growing in every area. What are the opportunities? What are the pitfalls?
The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower pricing is driving the Genetic Testing industry to record growth.
New drugs may only work for people with a certain genetic makeup, and this too is driving the Genetic Testing Industry. The traditional genetic testing market is growing in volume and growing in the breadth of tests creating new life, and new problems for the industry. The report includes detailed breakouts for 14 countries and 5 regions.
Predictive Diagnostics? Pharmacogenomic Testing? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.
This research makes you the expert in your organization. Make investment decisions and valuations with confidence using the latest data.
Key Topics Covered:
1 Market Guides
1.1 Genetic Testing - Strategic Situation Analysis & Company Rankings
1.1.1 Selected Genetic Testing Companies Revenue & Growth
1.1.2 Selected Companies Growth Chart
1.2 Guide for Executives, Marketing, Sales and Business Development Staff
1.3 Guide for Management Consultants and Investment Advisors
2 Introduction and Market Definition
2.1 Genetic Testing Definition in This Report
2.2 The Genomics Revolution
2.3 Market Definition
2.3.1 Revenue Market Size
2.3.2 Newborn Screening
2.3.3 Non Invasive Pregnancy Testing
2.3.4 Predictive
2.3.5 Oncology
2.3.6 Direct to Consumer
2.3.7 Other Application
2.3.8 PCR
2.3.9 NGS
2.3.10 Cytogenetic
2.3.11 Other Technology
2.4 Methodology
2.4.1 Methodology
2.4.2 Sources
2.4.3 Authors
2.5 Perspective: Healthcare and the IVD Industry
2.5.1 Global Healthcare Spending
2.5.2 Spending on Diagnostics
2.5.3 Important Role of Insurance for Diagnostics
2.6 Chromosomes, Genes and Epigenetics
2.6.1 Chromosomes
2.6.2 Genes
2.6.3 Epigenetics
3 Market Overview
3.1 Players in a Dynamic Market
3.1.1 Academic Research Lab
3.1.2 Diagnostic Test Developer
3.1.3 Instrumentation Supplier
3.1.4 Chemical/Reagent Supplier
3.1.5 Pathology Supplier
3.1.6 Independent Clinical Laboratory
3.1.7 Public National/regional Laboratory
3.1.8 Hospital Laboratory
3.1.9 Physicians Office Lab (POLS)
3.1.10 Audit Body
3.1.11 Certification Body
3.2 Genetic Tests - Types, Examples and Discussion
3.2.1 Preimplantation Genetic Diagnosis - An Emerging Market
3.2.2 Prenatal Diagnosis - New Technologies Create Opportunity
3.2.3 Newborn Screening
3.2.4 Diagnostic Testing
3.2.5 Carrier Testing
3.2.6 Predictive and Presymptomatic Testing
3.2.7 Pharmacogenomics
3.2.8 Forensic Testing
3.2.9 Parental Testing
3.2.10 Ancestral Testing
3.3 Industry Structure
3.3.1 Hospital's Testing Share
3.3.2 Economies of Scale
3.3.3 Hospital vs. Central Lab
3.3.4 Physician Office Lab's
3.3.5 Physician's and POCT
4 Market Trends
4.1 Factors Driving Growth
4.1.1 Genetic Discoveries Creating New Diagnostic Markets
4.1.2 The Aging Effect
4.1.3 Pharmacogenomics Drives Further Growth
4.1.4 Oncology and Liquid Biopsy Enter New Era
4.1.5 Fertility Practice Growth drives market
4.1.6 Direct to Consumer begins to break out
4.2 Factors Limiting Growth
4.2.1 Increased Competition Lowers Price
4.2.2 Lower Costs
4.2.3 Testing usage analysis curtailing growth
4.2.4 Wellness has a downside
4.3 Instrumentation, Automation and Diagnostic Trends
4.3.1 Traditional Automation and Centralization
4.3.2 The New Automation, Decentralization and Point of Care
4.3.3 Instruments Key to Market Share
4.3.4 Bioinformatics Plays a Role
4.3.5 PCR Takes Command
4.3.6 Next Generation Sequencing Fuels a Revolution
4.3.7 NGS Impact on Pricing
4.3.8 Whole Genome Sequencing, A Brave New World
4.3.9 Companion Diagnostics Blurs Diagnosis and Treatment
4.3.10 Shifting Role of Diagnostics
5 Genetic Testing Recent Developments
5.1 Recent Developments
5.1.1 Importance of This Section
5.1.2 How to Use This Section
5.2 Novitas Rescinds Coverage for Multiple Genetic Tests
5.3 PerkinElmer (now Revvity) Becomes Dx Life Science Firm
5.4 New POC Genotyping Tests Based on Electromagnetic Detection
5.5 GenoMe Dx Launching dPCR Cancer Test
5.6 mDetect To Trial Breast Cancer Liquid Biopsy
5.7 Genomics England, Aims to Sequence 100K Newborns
5.8 Juno Diagnostics NIPT With At-Home Sample Collection
5.9 Cardio Diagnostics Launches Genetic Cario Risk Test
5.10 Universal Genetic Testing in Breast Cancer Further Supported
5.11 Aniling Gets CE-IVD Marks for Cancer Sequencing Tests
5.12 MyOme Lands Investment for WGS
5.13 Type 2 Diabetes GWAS Enables Risk Prediction
5.14 LetsGetChecked to Acquire Veritas Genetics
5.15 Guardant Health Plans New Comprehensive Assay
5.16 Tesis Labs Raises $20M
5.17 Sema4: Sema4 Elements
5.18 Clarified Precision Medicine Acquires Interpares Biomedicine
5.19 Genetic Technologies to Acquire DTC Genetic Test Provider EasyDNA
5.20 Illumina, Belgium Genetic Centers Partner on WGS-Based Dx
6 Profiles of Key Companies
6.1 10x Genomics, Inc.
6.4 Adaptive Biotechnologies
6.6 Agilent/Dako
6.10 Anchor Dx
6.11 Arc Bio
6.14 Aus Diagnostics
6.15 BaseClear
6.16 Baylor Miraca Genetics Laboratories
6.23 BioFluidica
6.26 bioMerieux Diagnostics
6.29 Bio-Techne
6.31 CareDx
6.33 CellMax Life
6.35 Cepheid (Danaher)
6.36 Circulogene
6.37 Clinical Genomics
6.38 Color Genomics
6.39 Complete Genomics, Inc. - A BGI Company
6.40 CosmosID
6.43 Diasorin S.p.A.
6.48 Eurofins Scientific
6.50 Fabric Genomics
6.51 Freenome
6.52 Fujirebio
6.54 Gene by Gene, Ltd.
6.58 Genomics England
6.59 Genomics Personalized Health (GPH)
6.62 Grifols
6.63 Guardant Health
6.64 Guardiome
6.65 HeiScreen
6.66 Helix
6.67 Helix OpCo
6.68 Helomics
6.69 Hologic
6.72 iCellate
6.73 Illumina
6.74 Incell Dx
6.75 Inivata
6.76 Integrated Diagnostics
7 Global Market Size
7.1 Global Market by Country
7.2 Global Market by Application
7.3 Global Market by Technology
7.4 Global Market by Product
7.5 Global Market by User
8 Market Sizes by Application
8.1 Newborn Testing Market
8.2 NIPT Market
8.3 Predictive Testing Market
8.4 Oncology Testing Market
8.5 DTC Testing Market
9 Global Genetic Testing Market by Technology
9.1 PCR Testing Market
9.2 NGS Market
9.3 Cytogenetic Testing Market
10 Global Genetic Testing Market by Product
10.1 Instruments Market
10.2 Reagents and Kits Market
10.3 Software Market
10.4 Services Market
11 Global Genetic Testing Market by User
11.1 Academic Market
11.2 Clinical Market
11.3 Pharmaceutical Market
11.4 Industrial and Other Market
12 The Future of Genetic Testing
13 Appendices
13.1 United States Medicare System: Laboratory Fees Schedule
13.2 The Most Used IVD Assays
13.3 The Highest Grossing Assays
For more information about this report visit https://www.researchandmarkets.com/r/xnebxx
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
Drugs
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.